CHRISTOPHER BUNKA - 26 Apr 2024 Form 4 Insider Report for Lexaria Bioscience Corp. (LEXX)

Signature
/Chris Bunka/
Issuer symbol
LEXX
Transactions as of
26 Apr 2024
Net transactions value
$0
Form type
4
Filing time
10 May 2024, 16:44:46 UTC
Previous filing
30 Oct 2023
Next filing
10 Jan 2025

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding LEXX common shares 273,543 26 Apr 2024 Direct
holding LEXX common shares 254,412 26 Apr 2024 Private Holding Company

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction LEXX Stock Options Award $0 +49,500 +38% $0.000000 180,501 26 Apr 2024 Common Shares 49,500 $2.36 Direct
holding LEXX Warrants 6,667 26 Apr 2024 Common Shares 6,667 $10.50 Private Holding Company
holding LEXX Stock Options 32,667 26 Apr 2024 Common Shares 26,000 $3.00 Direct F1
holding LEXX Stock Options 56,001 26 Apr 2024 Common Shares 23,334 $3.00 Direct F2
holding LEXX Stock Options 71,001 26 Apr 2024 Common Shares 15,000 $3.00 Direct F3
holding LEXX Stock Options 101,001 26 Apr 2024 Common Shares 30,000 $2.91 Direct
holding LEXX Stock Options 131,001 26 Apr 2024 Common Shares 30,000 $1.15 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Repriced from $5.83 pursuant to shareholder approval received on May 9, 2023
F2 Repriced from $7.08 pursuant to shareholder approval received on May 9, 2023
F3 Repriced from $6.23 pursuant to shareholder approval received on May 9, 2023